Axonics News

Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Keese Kari Leigh

Oct 4 07:26

Axonics | 10-Q: Q2 2024 Earnings Report

Aug 2 04:14

Axonics | 8-K: Axonics Reports Second Quarter 2024 Financial Results

Aug 2 04:10

Axonics | 4: Statement of changes in beneficial ownership of securities-Officer COHEN RAYMOND W

Jul 26 07:34

Axonics | 8-K: Axonics Reports First Quarter 2024 Financial Results

May 1 04:51

Axonics | 10-Q: Q1 2024 Earnings Report

May 1 04:35

Axonics | 10-K/A: Annual report (Amendment)

Apr 30 04:46

Axonics | 8-K: Current report

Apr 4 20:00

Axonics | 8-K: Current report

Mar 26 04:04

Axonics | DEFA14A: Others

Mar 8 06:26

Axonics | 10-K: FY2023 Annual Report

Mar 1 03:19

Axonics | 8-K: Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 29 05:10

Axonics | DEFM14A: Definitive proxy statement relating to merger or acquisition

Feb 22 21:01

Axonics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(10.38%)

Feb 14 06:09

Axonics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(2.322%),Abigail P. Johnson(2.322%)

Feb 13 01:05

Axonics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(10.710%),Abigail P. Johnson(10.710%)

Feb 9 21:39

Axonics | PREM14A: Preliminary proxy statements relating to merger or acquisition

Feb 8 03:34

Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Sama Rinda

Feb 3 07:02

Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Noblett Karen

Feb 3 07:01

Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Woock John

Feb 3 07:01